KLK3 and cancer: These rapid increases in incidence were followed by sharp reductions, probably reflecting depletion of the number of prevalent latent cancers in the general population and subsequent reductions in PSA testing.23,24 In other countries, including several in Europe, less marked but similar patterns were noted, suggesting a later and more gradual adoption of PSA testing (figure 4).